Search Results

Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases.

• Authors : Ciechomska M; National Institute of Geriatrics Rheumatology and Rehabilitation, Department of Pathophysiology and Immunology, Warsaw, Poland.; O'Reilly S

Subjects: Epigenesis, Genetic/Epigenesis, Genetic/Epigenesis, Genetic/*genetics ; Epigenesis, Genetic/Epigenesis, Genetic/Epigenesis, Genetic/*physiology ; Rheumatic Diseases/Rheumatic Diseases/Rheumatic Diseases/*drug therapy

• Source: Mediators of inflammation [Mediators Inflamm] 2016; Vol. 2016, pp. 9607946. Date of Electronic Publication: 2016 Aug 10.Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1466-1861

Record details

Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature.

• Authors : Bazsó A; National Institute of Rheumatology and Physiotherapy, Frankel Leó Utca 38-40, Budapest 1023, Hungary.; Szodoray P

Subjects: Autoimmune Diseases/Autoimmune Diseases/Autoimmune Diseases/*diagnosis ; Psoriasis/Psoriasis/Psoriasis/*diagnosis ; Rheumatic Diseases/Rheumatic Diseases/Rheumatic Diseases/*diagnosis

• Source: Mediators of inflammation [Mediators Inflamm] 2015; Vol. 2015, pp. 657907. Date of Electronic Publication: 2015 Aug 03.Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1466-1861

Record details

Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases.

• Authors : Le Goff B; Service de Rhumatologie, Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093 Nantes Cedex 1, France.; INSERM UMR 1238 Phy-OS, 1 Rue Gaston Veil, 44035 Nantes Cedex 1, France.

Subjects: Cytokines/Cytokines/Cytokines/*metabolism ; Interleukin-17/Interleukin-17/Interleukin-17/*therapeutic use ; Rheumatic Diseases/Rheumatic Diseases/Rheumatic Diseases/*metabolism

• Source: Mediators of inflammation [Mediators Inflamm] 2019 Aug 14; Vol. 2019, pp. 8659302. Date of Electronic Publication: 2019 Aug 14 (Print Publication:Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: eCollection Cited Medium: Internet ISSN: 1466-1861

Record details

The Role of IL-1β in the Bone Loss during Rheumatic Diseases.

• Authors : Ruscitti, Piero¹ ; Cipriani, Paola¹ ; Carubbi, Francesco¹

• Source: Mediators of Inflammation. 4/12/2015, Vol. 2015, p1-10. 10p.

Record details

Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases.

• Authors : Scotece, Morena¹; Conde, Javier¹; Gómez, Rodolfo²

• Source: Mediators of Inflammation. 2012, Vol. 2012, p1-14. 14p. 3 Diagrams.

Record details

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases

• Authors : Rossana Scrivo; Massimiliano Vasile; Ulf Müller-Ladner

Subjects: Pathology; RB1-214

• Source: Mediators of Inflammation, Vol 2013 (2013)

Record details

Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases

• Authors : P. Vergne; V. Praloran; R. Treves

Subjects: Pathology; RB1-214

• Source: Mediators of Inflammation, Vol 6, Iss 3, Pp 241-242 (1997)

Record details

Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases

• Authors : V. Praloran; R. Treves; P. Vergne

Subjects: business.industry; Immunology; Cell Biology

• Source: Mediators of Inflammation, Vol 6, Iss 3, Pp 241-242 (1997)Mediators of Inflammation

Record details

Effects of Anti-Cytokine Antibodies on Gut Barrier Function.

• Authors : Liu F; Department of General Surgery and Central Lab, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.

Subjects: Antibodies/Antibodies/Antibodies/*therapeutic use ; Cytokines/Cytokines/Cytokines/*antagonists & inhibitors ; Cytokines/Cytokines/Cytokines/*immunology

• Source: Mediators of inflammation [Mediators Inflamm] 2019 Nov 12; Vol. 2019, pp. 7028253. Date of Electronic Publication: 2019 Nov 12 (Print Publication:Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: eCollection Cited Medium: Internet ISSN: 1466-1861

Record details

Atherosclerosis and Autoimmunity.

• Authors : Spinelli FR; Sapienza Università di Roma, Rome, Italy.; Barone F

Subjects: Atherosclerosis/Atherosclerosis/Atherosclerosis/*metabolism ; Autoimmunity/Autoimmunity/Autoimmunity/*physiology; Animals

• Source: Mediators of inflammation [Mediators Inflamm] 2018 Mar 29; Vol. 2018, pp. 6730421. Date of Electronic Publication: 2018 Mar 29 (Print Publication:Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: eCollection Cited Medium: Internet ISSN: 1466-1861

Record details